Found 6 matching trials
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer PHASE2 Study design: Prospective, single-arm, single-center phase II clinical stud...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE2 This is a single-center, single-arm, open-label, phase 2 clinical study, to...
Show More Status
Active Not Recruiting
Location
Cancer center of SunYat-sen University
Learn More & Join Trial
Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC. PHASE2 For unresectable and metastatic advanced biliary tract cancers (BTCs), gemc...
Show More Status
Active Not Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma PHASE2 Evaluation of Efficacy and Safety of Sintilimab Plus Bevacizumab and AG Reg...
Show More Location
the Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ยฑ Chemotherapy in Patients With Advanced Digestive System Tumors PHASE2 This is a prospective, open-label, exploratory, phase II basket clinical tr...
Show More Learn More & Join Trial
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer PHASE2 This is a Phase II, prospective, single-arm exploratory clinical trial desi...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial